In clinical routine pathology, the identification of TERT promoter mutations may also help verify if the suspicious cell population is truly neoplastic, rather than tumor-associated reactive spindle cell areas frequently observed in chondrosarcomas. This evidence concerns the gene TERT and chondrosarcoma.